A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells.
about
Activated Ras as a Therapeutic Target: Constraints on Directly Targeting Ras Isoforms and Wild-Type versus Mutated ProteinsSmall-molecule inhibitors of the Rce1p CaaX proteaseChemical inhibition of CaaX protease activity disrupts yeast Ras localization.Ras oncogenes: split personalitiesTargeting protein lipidation in diseaseAmide-substituted farnesylcysteine analogs as inhibitors of human isoprenylcysteine carboxyl methyltransferase.A small molecule inhibitor of isoprenylcysteine carboxymethyltransferase induces autophagic cell death in PC3 prostate cancer cells.Modulation of heat shock transcription factor 1 as a therapeutic target for small molecule intervention in neurodegenerative diseaseAntimetabolites and cancer: emerging data with a focus on antifolates.Protein post-translational modifications: In silico prediction tools and molecular modeling.Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysisAlterations in molecular chaperones and eIF2alpha during lung endothelial cell apoptosisIsoprenylcysteine carboxylmethyltransferase is critical for malignant transformation and tumor maintenance by all RAS isoforms.Therapeutic intervention based on protein prenylation and associated modificationsAn improved isoprenylcysteine carboxylmethyltransferase inhibitor induces cancer cell death and attenuates tumor growth in vivo.Amide-modified prenylcysteine based Icmt inhibitors: Structure-activity relationships, kinetic analysis and cellular characterizationDevelopment of synthetic lethality anticancer therapeutics.Prelamin A, Zmpste24, misshapen cell nuclei, and progeria--new evidence suggesting that protein farnesylation could be important for disease pathogenesis.Targeting mutant KRAS for anticancer therapeutics: a review of novel small molecule modulators.Drugging the undruggable RAS: Mission possible?A role for Rac3 GTPase in the regulation of autophagy.Quantitative structure-activity relationship (QSAR) of indoloacetamides as inhibitors of human isoprenylcysteine carboxyl methyltransferase.The isoprenoid substrate specificity of isoprenylcysteine carboxylmethyltransferase: development of novel inhibitors.Synthesis of desthio prenylcysteine analogs: sulfur is important for biological activityNon-Substrate Based, Small Molecule Inhibitors of the Human Isoprenylcysteine Carboxyl Methyltransferase.Biogenesis of the Saccharomyces cerevisiae pheromone a-factor, from yeast mating to human disease.Inactivating Icmt ameliorates K-RAS-induced myeloproliferative disease.Role of transmethylation reactions in alcoholic liver disease.Solid-phase synthesis of prenylcysteine analogsIsoprenylcysteine carboxylmethyltransferase deficiency exacerbates KRAS-driven pancreatic neoplasia via Notch suppression.Ras acylation, compartmentalization and signaling nanoclusters (Review).Role of isoprenylcysteine carboxylmethyltransferase-catalyzed methylation in Rho function and migration.Heterologous expression studies of Saccharomyces cerevisiae reveal two distinct trypanosomatid CaaX protease activities and identify their potential targets.A RAS renaissance: emerging targeted therapies for KRAS-mutated non-small cell lung cancer.Regulating the regulator: post-translational modification of RASRho GTPase signaling in the development of colorectal cancer.Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery?Current status of the development of Ras inhibitors.The renewed battle against RAS-mutant cancers.Isoprenylcysteine carboxylmethyltransferase regulates mitochondrial respiration and cancer cell metabolism.
P2860
Q27027458-DA3E3DBF-0ED4-42B1-9AF0-5EBE99E1A381Q27932239-95C908BB-6098-4D2C-9F1D-E9CFF3C685AFQ27937343-327D72F4-E0F2-402F-BCB9-DE0CD72EC460Q29615405-CFE649D8-DB95-4A06-8C86-FF343F6318FBQ30413212-DB7696C0-B37E-441C-8B62-4E784060C41BQ33246884-8CEBFECC-F995-41F9-9E18-EC8AABB97831Q33330582-A4C95A75-8465-4AEE-B96B-B4592D33B40CQ33526350-FA5C2DCC-6A66-483F-9921-10DF6FB27E57Q33530405-C86195C1-CF86-422A-BB5B-68BD20A757D0Q33580119-B08D3016-A0B6-4B77-8B9C-E838CD2E624AQ33679330-564E138C-FF4B-44BA-8C92-91BECD65FBEFQ33784115-70F7999A-F64C-4FEF-8491-D7FDD244C8C8Q33886255-7E54E75C-AC8D-4DBC-964E-6B7AA59BD86EQ33943379-587D15C0-001A-426B-BE71-77E0E36BC054Q34028492-66C5FAD0-5D70-4BF8-9A53-04652D9FEA66Q34091952-6BEEC6F6-0025-4CD6-804A-F548D0EB7976Q34380368-403991BA-6FF7-4078-950F-A7C8B69F2E3DQ34457223-ABD2A726-6010-470C-82C1-571F45EB9F09Q34659415-31FE5212-38D8-4438-A387-C43843000B5CQ35163434-4D4940A0-AC35-4086-8328-9879B462D88EQ35266447-4158D155-F42E-4F87-81DD-ED5D4782B068Q35928477-F0B12EA6-D49B-4576-A3EA-AF60EE012E22Q36107479-946E1E92-3A56-464E-8B9C-CBB786B1C956Q36107507-AA85DE43-DE0B-4702-88C2-4C27300B1444Q36108766-41BB10FB-FEC1-4817-9939-B3A8F6085A74Q36194945-A35B4F9B-60D7-4B3C-BDF0-9750DC10726AQ36835230-C69A6727-E641-4A9F-A79A-CD61324DD67AQ36939985-FBA55569-607C-42EC-82E9-CE6FE92A7CF4Q37243140-858E1744-9A8C-4EA7-972D-AD86B9D925DBQ37259201-0C46686D-04F0-481E-9D56-4723CE7D017AQ37359986-0E92CB16-F72E-45FA-9072-3E3E822CD7C6Q37459898-E195E504-E3F8-460E-873A-91F6B33C6FB7Q37477703-4A7BA5CC-65AC-40A3-A394-ACABD1DFE371Q37724940-88409A65-C7CB-4CD6-897D-C1C6675C1DE6Q37970568-660BA877-A376-488F-AD16-7DD3EF7361D8Q37998994-34EFEDB8-7BB9-4219-8906-B33B17F85B25Q38423044-F22E5120-69AE-4D5E-BBFE-FEEE464D68A7Q38534932-030CECAE-6EDA-4A27-8AAF-C82C48B24776Q38740000-C0EE5E1B-ABBE-42F5-A7F1-BBD242CC3776Q38963320-C713D3DA-8955-4062-A64E-1254CC65B2AF
P2860
A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
A small-molecule inhibitor of ...... umor activity in cancer cells.
@ast
A small-molecule inhibitor of ...... umor activity in cancer cells.
@en
type
label
A small-molecule inhibitor of ...... umor activity in cancer cells.
@ast
A small-molecule inhibitor of ...... umor activity in cancer cells.
@en
prefLabel
A small-molecule inhibitor of ...... umor activity in cancer cells.
@ast
A small-molecule inhibitor of ...... umor activity in cancer cells.
@en
P2093
P2860
P356
P1476
A small-molecule inhibitor of ...... tumor activity in cancer cells
@en
P2093
Ann M Winter-Vann
David M Gooden
Eric J Toone
John D York
June dela Cruz
Martin O Bergo
Patrick J Casey
Rudi A Baron
Waihay Wong
P2860
P304
P356
10.1073/PNAS.0408107102
P407
P577
2005-03-01T00:00:00Z